On Tuesday, the FDA updated its website to reflect new guidelines on abortion pill access, which now allows retail pharmacies to carry mifepristone which, used alongside misoprostol, causes the deaths of unborn babies at early stages of development. Pharmacies can become certified to distribute the drug by completing an agreement form, as previously reported by LifeSiteNews.
(read more)